CSL有限公司宣布达成一项独家授权协议,获得针对Clazakizumab的特定开发及商业化权利。该协议进一步拓展了公司在创新疗法领域的战略布局。
CSL有限公司宣布达成一项独家授权协议,获得针对Clazakizumab的特定开发及商业化权利。该协议进一步拓展了公司在创新疗法领域的战略布局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.